Our top content coverage from the Conference on Retroviruses and Opportunistic Infections (CROI) 2025 highlighted developments in several infectious diseases, including the safety of the HIVconsvX vaccine in those taking antiretroviral therapy…

Our top content coverage from the Conference on Retroviruses and Opportunistic Infections (CROI) 2025 highlighted developments in several infectious diseases, including the safety of the HIVconsvX vaccine in those taking antiretroviral therapy…